Gear International, Inc. (PINK:GEAR) reached up 89.66% in morning trading to $.044 with 16M shares traded. Gear International, Inc. was originally incorporated in 1996. The company's strategically focused on gold and silver mining, providing financing for gold and silver mining projects, and precious metals processing and refining. Gear International, Inc. (GEAR.PK) yesterday released financial statements demonstrating significant improvement in asset value and cash on balance from 2010 to the current fiscal year. Complemented by a series of asset acquisitions and joint venture agreements on several mining claims, the underlying company financials suggest a fundamental enhancement of shareholder value could soon be realized. GEAR has added 5 mining claims and improved its cash reserves. Additionally, GEAR management is anticipating a market correction in the value of the company's stock after successfully eliminating a hostile shareholder from the float.
Cuba Beverage Company (PINK:CUBV) reached up 26.67% in morning trading to $.19 with 500K shares traded. Cuba Beverage Company is at the forefront of creating a unique category for Herbal Energy Juices in the global energy beverage market. Developed over the past four years with leading industry scientists, CUBA Herbal Energy Juice® is the first ready-to-drink beverage by Cuba Beverage Company that offers a healthy, natural alternative to conventional energy drinks. Cuba Beverage Company (CUBV.PK) announced today that it has executed a distribution agreement with Hom's Enterprise to bring its line of CUBA Herbal Energy Juice® to China. The distributor has forecasted approximately 20,000 cases of Cuba products will be sold in Mainland China this year, which is valued to add US$360,000 in sales to Cuba Beverage in 2012.
Keryx Biopharmaceuticals, Inc. (NasdaqCM:KERX) reached up 16.82% in morning trading to $1.799 with 1.5M shares traded. Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease. Keryx is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of Zerenex for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is being conducted pursuant to a Special Protocol Assessment (SPA) agreement with the FDA. Keryx is headquartered in New York City. Keryx Biopharmaceuticals, Inc. (KERX) today announced that an abstract highlighting the dose related increases in iron storage parameters as observed in prior clinical trials of Zerenex™ (ferric citrate), has been accepted for poster presentation at the upcoming 49th ERA-EDTA (European Renal Association – European Dialysis and Transplant Association) Congress, taking place May 24-27, 2012, in Paris, France.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at email@example.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE